Work

Poster: ALL-049 A Phase 1/2 Study to Evaluate Ponatinib With Chemotherapy in Pediatric Patients With Relapsed/Resistant/Intolerant Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia or With T315I Mutation

Year: 2022

Type: article

Source: Clinical Lymphoma Myeloma & Leukemia

DOI: 10.1016/s2152-2650(22)00733-9

Authors: Lia Gore, Mignon Loh, Ching-Hon Pui, Yousif Matloub, Michael J. Hanley, Jichang Du, Meliessa Hennessy, Muriel Granier, Andrea Biondi, Lewis Silverman

Institution: University of Colorado Cancer Center

Language: English

Topic: Acute Lymphoblastic Leukemia research

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4296531544

FWCI:

Cites:

Cited by:

Related to: 10